Selected References:
- Centers for Disease Control and Prevention. 2025. About RSV. Available at https://www.cdc.gov/rsv/about/index.html. Accessed 4 March 2026.
- Centers for Disease Control and Prevention. 2024. RSV Vaccine Guidance for Pregnant Women. Available at https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/pregnant-people.html. Accessed 4 March 2026.
- DeSilva M. 2025. Prenatal RSVpreF Vaccine Safety 2023–2024 Respiratory Season: The Vaccine Safety Datalink (VSD). Centers for Disease Control and Prevention. Presented at: Meeting of the Advisory Committee on Immunization Practices (ACIP); June 25, 2025; Atlanta, Georgia. Available at: https://www.cdc.gov/acip/downloads/slides-2025-06-25-26/04a-DeSilva-Mat-Peds-RSV-508.pdf. Accessed 4 March 2026.
- Fleming-Dutra KE, et al. 2023. Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb Mortal Wkly Rep; 72(41):1115-1122.
- Kampmann B, et al. 2023. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med; 388:1451-146.
- Marchand GJ, et al. 2024. RSVpreF vaccination in pregnancy: a meta-analysis of maternal-fetal safety and infant efficacy. Obstet Gynecol Sci 67(6): 511-524.
- Michnick AI, et al. 2026. Interim safety of RSVpreF vaccination during pregnancy. JAMA. 335(5):456–459.
- U.S. Food and Drug Administration. 2023 (Revised 2025). AbrysvoTM Prescribing Information. Available at: https://www.fda.gov/media/168889/download. Accessed 4 March 2026.
- Son M, et al. 2024. Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes. JAMA Netw Open; 7(7):e2419268.
